Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Irradiation in the Production, Processing, and Handling of Food, 23865-23866 [E9-11931]
Download as PDF
23865
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
impractical or when in-depth responses
are required.
The evaluation information will be
used to determine whether DHDSP
activities and products are reaching the
intended audiences, whether they are
deemed to be useful by those audiences,
and whether DHDSP efforts improve
public health practices. Finally, the
generic clearance format will allow the
DHDSP to identify new programmatic
opportunities and to respond to
partners’ concerns.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
491.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Data collection mechanism
State and Local Health Departments ...........................
Web-based survey ........................................................
Interview .......................................................................
Focus group ..................................................................
Web-based survey ........................................................
Interview .......................................................................
Focus group ..................................................................
Web-based survey ........................................................
Interview .......................................................................
Focus group ..................................................................
Private Sector Partners ................................................
Academic Institutions ....................................................
Dated: May 14, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–11895 Filed 5–20–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0043]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Irradiation in the
Production, Processing, and Handling
of Food
AGENCY:
Food and Drug Administration,
HHS.
dwashington3 on PROD1PC60 with NOTICES
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by June 22,
2009.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–6974, or e-mailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–0186. Also
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
include the FDA docket number found
in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of Information
Management (HFA–710), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301–796–3794.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
Irradiation in the Production,
Processing, and Handling of Food—
(OMB Control Number 0910–0186)—
Extension
Under sections 201(s) and 409 of the
Federal Food, Drug, and Cosmetic Act
(the act) (21 U.S.C. 321(s) and 348), food
irradiation is subject to regulation under
the food additive premarket approval
provisions of the act. The regulations
providing for uses of irradiation in the
production, processing, and handling of
food are found in part 179 (21 CFR part
179). To ensure safe use of a radiation
source, § 179.21(b)(1) requires that the
label of sources bear appropriate and
accurate information identifying the
source of radiation and the maximum
(or minimum and maximum) energy of
radiation emitted by x-ray tube sources.
Section 179.21(b)(2) requires that the
label or accompanying labeling bear
adequate directions for installation and
use and a statement supplied by FDA
that indicates maximum dose of
radiation allowed. Section 179.26(c)
requires that the label or accompanying
labeling bear a logo and a radiation
disclosure statement. Section 179.25(e)
requires that food processors who treat
food with radiation make and retain, for
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
250
30
32
180
90
48
60
30
16
Average
burden per
response
(in hours)
30/60
1
1
30/60
1
1
30/60
1
1
1 year past the expected shelf life of the
products up to a maximum of 3 years,
specified records relating to the
irradiation process (e.g., the food
treated, lot identification, scheduled
process, etc.). The records required by
§ 179.25(e) are used by FDA inspectors
to assess compliance with the regulation
that establishes limits within which
radiation may be safely used to treat
food. The agency cannot ensure safe use
without a method to assess compliance
with the dose limits, and there are no
practicable methods for analyzing most
foods to determine whether they have
been treated with ionizing radiation and
are within the limitations set forth in
part 179. Records inspection is the only
way to determine whether firms are
complying with the regulations for
treatment of foods with ionizing
radiation.
In this request for extension of OMB
approval, FDA proposes to include and
consolidate into the subject collection of
information (OMB control number
0910–0186) the collection of
information and associated burden
hours from OMB control number 0910–
0549. This inclusion is reflected in the
estimated burden reported in table 1 of
this document, which has increased by
the addition of one recordkeeper in the
large processors line, increasing the
number of estimated recordkeepers from
two to three.
Description of Respondents:
Respondents are businesses engaged in
the irradiation of food.
In the Federal Register of February
13, 2009 (74 FR 7236), FDA published
a 60-day notice requesting public
comment on the information collection
provisions. No comments were received.
E:\FR\FM\21MYN1.SGM
21MYN1
23866
Federal Register / Vol. 74, No. 97 / Thursday, May 21, 2009 / Notices
FDA estimates the burden of this
collection of information as follows:
TABLE 1.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 CFR Section
No. of
Recordkeepers
Annual Frequency
per Recordkeeping
Total Annual
Records
Hours per
Record
Total Hours
179.25(e), large processors
3
300
900
1
900
179.25(e), small processors
4
30
120
1
120
Total
1There
1,020
are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of burden for
the recordkeeping provisions of
§ 179.25(e) on the agency’s experience
regulating the safe use of radiation as a
direct food additive. The number of
firms who process food using irradiation
is extremely limited. FDA estimates that
there are 3 irradiation plants whose
business is devoted primarily (i.e.,
approximately 100 percent) to
irradiation of food and other agricultural
products. Four other firms also irradiate
small quantities of food. FDA estimates
that this irradiation accounts for no
more than 10 percent of the business for
each of these firms. Therefore, the
average estimated burden is based on:
Three facilities devoting 100 percent of
their business to food irradiation (3 ×
300 hours = 900 hours for recordkeeping
annually); four facilities devoting 10
percent of their business to food
irradiation (4 × 30 hours = 120 hours for
recordkeeping annually).
No burden has been estimated for the
labeling requirements in § 179.21(b)(1)
and (b)(2) and § 179.26(c) because the
information to be disclosed is
information that has been supplied by
FDA. Under 5 CFR 1320.3(c)(2), the
public disclosure of information
originally supplied by the Federal
Government to the recipient for the
purpose of disclosure to the public is
not a collection of information.
Dated: May 14, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
dwashington3 on PROD1PC60 with NOTICES
[FR Doc. E9–11931 Filed 5–20–09; 8:45 am]
BILLING CODE 4160–01–S
VerDate Nov<24>2008
13:08 May 20, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases
Diabetes Mellitus Interagency
Coordinating Committee; Notice of
Meeting
The National Institute of Diabetes and
Digestive and Kidney Diseases (NIDDK),
on behalf of the National Institutes of
Health (NIH), the Centers for Disease
Control and Prevention (CDC), and the
Diabetes Mellitus Interagency
Coordinating Committee (DMICC), is
convening an ad hoc planning and
evaluation meeting to provide a midcourse assessment of ongoing preclinical research efforts supported by
the Special Statutory Funding Program
for Type 1 Diabetes Research and to
discuss possible future directions for
these efforts.
Sessions of the meeting will be open
to the public as indicated below, with
attendance limited to space available.
Certain sessions, during which
confidential information will be
discussed, will be closed to the public.
Members of the public planning to
attend the meeting must register online
at: https://www.scgcorp.com/
Type1Diabetes09/registration.asp. This
is not a meeting to solicit public
comment. Therefore, members of the
public are permitted to attend the open
sessions as observers only. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should inform the
Contact Person listed below at least 10
days in advance of the meeting.
Name: Meeting on Pre-Clinical
Research Supported by the Special
Statutory Funding Program for Type 1
Diabetes Research.
Place: National Institutes of Health,
Neuroscience Building, 6001 Executive
Blvd., Conference Room C, Bethesda,
MD 20852.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Date: June 17, 2009.
Open: 8 a.m. to 8:45 a.m.
Agenda: Meeting introduction;
overview of the Type 1 Diabetes—Rapid
Access to Intervention Development
(T1D–RAID) research program.
Closed: 8:45 a.m. to 9:30 a.m.
Agenda: Mid-course assessment of
T1D–RAID.
Open: 9:30 a.m. to 10 a.m.
Agenda: Overview of the Type 1
Diabetes Preclinical Testing Program
(T1D–PTP)—Prevention or Reversal of
Type 1 Diabetes in Rodent Models.
Closed: 10 a.m. to 10:30 a.m.
Agenda: Mid-course assessment of the
T1D–PTP—Prevention or Reversal of
Type 1 Diabetes in Rodent Models.
Open: 10:45 a.m. to 11:15 a.m.
Agenda: Overview of the T1D–PTP—
Prevention or Reversal of Diabetic
Complications in Rodent Models.
Closed: 11:15 a.m. to 11:45 a.m.
Agenda: Mid-course assessment of the
T1D–PTP—Prevention or Reversal of
Diabetic Complications in Rodent
Models.
Open: 12:30 p.m. to 1 p.m.
Agenda: Overview of the Animal
Models of Diabetic Complications
Consortium (AMDCC) research program.
Closed: 1 p.m. to 2 p.m.
Agenda: Mid-course assessment of the
AMDCC.
Open: 2 p.m. to 2:30 p.m.
Agenda: Overview of the Type 1
Diabetes Resource.
Closed: 2:30 p.m. to 3:15 p.m.
Agenda: Mid-course assessment of the
Type 1 Diabetes Resource.
Open: 3:30 p.m. to 4 p.m.
Agenda: Overview of Beta Cell
Biology Consortium (BCBC).
Closed: 4 p.m. to 5 p.m.
Agenda: Mid-course assessment of the
BCBC.
Contact Person: Julie Wallace, PhD,
Health Science Policy Analyst, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and
Digestive and Kidney Diseases, 9000
Rockville Pike, Building 31, Room
9A05, Bethesda, MD 20892, (301) 496–
6623, wallaceja@niddk.nih.gov.
E:\FR\FM\21MYN1.SGM
21MYN1
Agencies
[Federal Register Volume 74, Number 97 (Thursday, May 21, 2009)]
[Notices]
[Pages 23865-23866]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11931]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0043]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Irradiation in the
Production, Processing, and Handling of Food
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995.
DATES: Fax written comments on the collection of information by June
22, 2009.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
FAX: 202-395-6974, or e-mailed to oira_submission@omb.eop.gov. All
comments should be identified with the OMB control number 0910-0186.
Also include the FDA docket number found in brackets in the heading of
this document.
FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Information
Management (HFA-710), Food and Drug Administration, 5600 Fishers Lane,
Rockville, MD 20857, 301-796-3794.
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Irradiation in the Production, Processing, and Handling of Food--(OMB
Control Number 0910-0186)--Extension
Under sections 201(s) and 409 of the Federal Food, Drug, and
Cosmetic Act (the act) (21 U.S.C. 321(s) and 348), food irradiation is
subject to regulation under the food additive premarket approval
provisions of the act. The regulations providing for uses of
irradiation in the production, processing, and handling of food are
found in part 179 (21 CFR part 179). To ensure safe use of a radiation
source, Sec. 179.21(b)(1) requires that the label of sources bear
appropriate and accurate information identifying the source of
radiation and the maximum (or minimum and maximum) energy of radiation
emitted by x-ray tube sources. Section 179.21(b)(2) requires that the
label or accompanying labeling bear adequate directions for
installation and use and a statement supplied by FDA that indicates
maximum dose of radiation allowed. Section 179.26(c) requires that the
label or accompanying labeling bear a logo and a radiation disclosure
statement. Section 179.25(e) requires that food processors who treat
food with radiation make and retain, for 1 year past the expected shelf
life of the products up to a maximum of 3 years, specified records
relating to the irradiation process (e.g., the food treated, lot
identification, scheduled process, etc.). The records required by Sec.
179.25(e) are used by FDA inspectors to assess compliance with the
regulation that establishes limits within which radiation may be safely
used to treat food. The agency cannot ensure safe use without a method
to assess compliance with the dose limits, and there are no practicable
methods for analyzing most foods to determine whether they have been
treated with ionizing radiation and are within the limitations set
forth in part 179. Records inspection is the only way to determine
whether firms are complying with the regulations for treatment of foods
with ionizing radiation.
In this request for extension of OMB approval, FDA proposes to
include and consolidate into the subject collection of information (OMB
control number 0910-0186) the collection of information and associated
burden hours from OMB control number 0910-0549. This inclusion is
reflected in the estimated burden reported in table 1 of this document,
which has increased by the addition of one recordkeeper in the large
processors line, increasing the number of estimated recordkeepers from
two to three.
Description of Respondents: Respondents are businesses engaged in
the irradiation of food.
In the Federal Register of February 13, 2009 (74 FR 7236), FDA
published a 60-day notice requesting public comment on the information
collection provisions. No comments were received.
[[Page 23866]]
FDA estimates the burden of this collection of information as
follows:
Table 1.--Estimated Annual Recordkeeping Burden\1\
----------------------------------------------------------------------------------------------------------------
No. of Annual Frequency Total Annual
21 CFR Section Recordkeepers per Recordkeeping Records Hours per Record Total Hours
----------------------------------------------------------------------------------------------------------------
179.25(e), 3 300 900 1 900
large
processors
----------------------------------------------------------------------------------------------------------------
179.25(e), 4 30 120 1 120
small
processors
----------------------------------------------------------------------------------------------------------------
Total ................. .................... ................. ................. 1,020
----------------------------------------------------------------------------------------------------------------
\1\There are no capital costs or operating and maintenance costs associated with this collection of information.
FDA bases its estimate of burden for the recordkeeping provisions
of Sec. 179.25(e) on the agency's experience regulating the safe use
of radiation as a direct food additive. The number of firms who process
food using irradiation is extremely limited. FDA estimates that there
are 3 irradiation plants whose business is devoted primarily (i.e.,
approximately 100 percent) to irradiation of food and other
agricultural products. Four other firms also irradiate small quantities
of food. FDA estimates that this irradiation accounts for no more than
10 percent of the business for each of these firms. Therefore, the
average estimated burden is based on: Three facilities devoting 100
percent of their business to food irradiation (3 x 300 hours = 900
hours for recordkeeping annually); four facilities devoting 10 percent
of their business to food irradiation (4 x 30 hours = 120 hours for
recordkeeping annually).
No burden has been estimated for the labeling requirements in Sec.
179.21(b)(1) and (b)(2) and Sec. 179.26(c) because the information to
be disclosed is information that has been supplied by FDA. Under 5 CFR
1320.3(c)(2), the public disclosure of information originally supplied
by the Federal Government to the recipient for the purpose of
disclosure to the public is not a collection of information.
Dated: May 14, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and Planning.
[FR Doc. E9-11931 Filed 5-20-09; 8:45 am]
BILLING CODE 4160-01-S